A novel approach to the induction of specific cytolytic T cells in vivo

This publication has 18 references indexed in Scilit:

• Interleukin 2 gene transfer into tumor cells abrogates tumorigenicity and induces protective immunity.
  The Journal of Experimental Medicine, 1990
• Antiviral cytotoxic T cell response induced by in vivo priming with a free synthetic peptide.
  The Journal of Experimental Medicine, 1990
• Interleukin-2 production by tumor cells bypasses T helper function in the generation of an antitumor response
  Cell, 1990
• Class I-restricted processing and presentation of exogenous cell-associated antigen in vivo.
  The Journal of Experimental Medicine, 1990
• In vivo priming of virus-specific cytotoxic T lymphocytes with synthetic lipopeptide vaccine
  Nature, 1989
• Multiple subsets of HIV‐specific cytotoxic T lymphocytes in humans and in mice
  European Journal of Immunology, 1989
• Introduction of soluble protein into the class I pathway of antigen processing and presentation
  Cell, 1988
• Enhanced recognition of a modified peptide antigen by cytotoxic T cells specific for influenza nucleoprotein
  Cell, 1988
• Escape of mouse mastocytoma P815 after nearly complete rejection is due to antigen-loss variants rather than immunosuppression.
  The Journal of Experimental Medicine, 1983
• Viral specificity of H-2-restricted T killer cells directed against syngeneic tumors induced by Gross, Friend, or Rauscher leukemia virus.
  The Journal of Experimental Medicine, 1979